114 related articles for article (PubMed ID: 21048552)
21. Endothelial dysfunction and oxidative stress in chronic renal failure.
Ghiadoni L; Cupisti A; Huang Y; Mattei P; Cardinal H; Favilla S; Rindi P; Barsotti G; Taddei S; Salvetti A
J Nephrol; 2004; 17(4):512-9. PubMed ID: 15372412
[TBL] [Abstract][Full Text] [Related]
22. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
23. Relation of antioxidants and acute-phase reactants in patients receiving hemodialysis.
Samadian F; Lessan-Pezeshki M; Mahdavi-Mazdeh M; Kadkhodaie M; Seifi S; Ahmadi F
Iran J Kidney Dis; 2007 Jul; 1(1):38-42. PubMed ID: 19357443
[TBL] [Abstract][Full Text] [Related]
24. Markers of oxidative stress in the skeletal muscle of patients on haemodialysis.
Crowe AV; McArdle A; McArdle F; Pattwell DM; Bell GM; Kemp GJ; Bone JM; Griffiths RD; Jackson MJ
Nephrol Dial Transplant; 2007 Apr; 22(4):1177-83. PubMed ID: 17213227
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independent of severity: a cohort study.
Abilés J; de la Cruz AP; Castaño J; Rodríguez-Elvira M; Aguayo E; Moreno-Torres R; Llopis J; Aranda P; Argüelles S; Ayala A; de la Quintana AM; Planells EM
Crit Care; 2006; 10(5):R146. PubMed ID: 17040563
[TBL] [Abstract][Full Text] [Related]
26. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients.
Kim KM; Jung BH; Paeng KJ; Kim SW; Chung BC
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):475-8. PubMed ID: 15062851
[TBL] [Abstract][Full Text] [Related]
27. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
[TBL] [Abstract][Full Text] [Related]
28. Ethylene-vinyl alcohol copolymer dialyzer membrane reduces protein oxidation in hemodialysis patients.
Matsumoto Y; Mukai M; Arihara K; Saito T; Kumagai H
Ren Fail; 2011; 33(4):382-7. PubMed ID: 21529266
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide metabolites, leukocyte activation markers and oxidative status in dialyzed subjects.
Caimi G; Carollo C; Montana M; Iatrino R; Bondì B; Lo Presti R
Blood Purif; 2009; 27(2):194-8. PubMed ID: 19153478
[TBL] [Abstract][Full Text] [Related]
30. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
31. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation.
Morena M; Delbosc S; Dupuy AM; Canaud B; Cristol JP
Hemodial Int; 2005 Jan; 9(1):37-46. PubMed ID: 16191052
[TBL] [Abstract][Full Text] [Related]
32. [Oxidative stress in end stage renal disease: evidence and association with cardiovascular events in Tunisian patients].
Fellah H; Feki M; Souissi M; Ghorbel H; Ben Abdallah T; Massy Z; Hedhili A; Ben Maiz H; Lacour B; Kaabachi N; Mebazaa A
Tunis Med; 2006 Nov; 84(11):724-9. PubMed ID: 17294900
[TBL] [Abstract][Full Text] [Related]
33. Carbonyl stress in chronic renal failure: the effect of haemodialysis.
Dursun E; Dursun B; Süleymanlar G; Ozben T
Ann Clin Biochem; 2005 Jan; 42(Pt 1):64-6. PubMed ID: 15802036
[TBL] [Abstract][Full Text] [Related]
34. Serum trypsin inhibitory capacity in hemodialysis patients.
Hashemi M; Mehrabifar H; Homayooni F; Naderi M; Montazerifar F; Ghavami S
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):604-7. PubMed ID: 19587500
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
[TBL] [Abstract][Full Text] [Related]
36. The relationship between leptin level and oxidative status parameters in hemodialysis patients.
Horoz M; Aslan M; Koylu AO; Bolukbas C; Bolukbas FF; Selek S; Erel O
Artif Organs; 2009 Jan; 33(1):81-5. PubMed ID: 19178446
[TBL] [Abstract][Full Text] [Related]
37. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
38. Elastase, myeloperoxidase, nitric oxide metabolites and oxidative status in subjects with clinical stable chronic renal failure on conservative treatment.
Caimi G; Carollo C; Montana M; Vaccaro F; Lo Presti R
Clin Hemorheol Microcirc; 2009; 43(3):253-8. PubMed ID: 19847059
[TBL] [Abstract][Full Text] [Related]
39. Oxidative stress markers in pre-uremic patients.
Annuk M; Fellström B; Akerblom O; Zilmer K; Vihalemm T; Zilmer M
Clin Nephrol; 2001 Oct; 56(4):308-14. PubMed ID: 11680661
[TBL] [Abstract][Full Text] [Related]
40. N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients.
Hsu SP; Chiang CK; Yang SY; Chien CT
Nephron Clin Pract; 2010; 116(3):c207-16. PubMed ID: 20606481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
